- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02403037
Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients
The Effects of Auricular Acupressure on Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients: A Pilot Randomized Controlled Trial
To evaluate the feasibility of a three-parallel-arm, placebo-controlled randomized trial using a standard auricular acupressure protocol for managing nausea and vomiting in a homogenous group of female breast cancer patients undergoing chemotherapy.
The null hypotheses of this study are: (1) There will be no significant difference in acute/delayed nausea and vomiting among groups during the intervention period; (2) There will be no significant difference in anticipatory nausea and vomiting among groups before the second cycle of chemotherapy; (3) There will be no significant difference in quality of life status among groups at the end of the first cycle of chemotherapy.
Visão geral do estudo
Status
Condições
Descrição detalhada
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and distressing side-effects among cancer patients undergoing chemotherapy. Despite steady progresses in antiemetic prophylaxis and treatment during the past decades, approximately half of cancer patients receiving moderately to highly emetogenic chemotherapy still experience significant nausea and vomiting. Considering the facts that CINV is difficult to be completely controlled by antiemetics along, healthcare professionals has explored the role of non-pharmacological interventions as adjunctive therapy for controlling CINV. Among which, auricular therapy (AT) is a promising approach but the evidence has still not been concluded.
The aim of this study is to test the feasibility of a randomized controlled trial using auricular acupressure protocol for managing nausea and vomiting in female breast cancer patients undergoing chemotherapy. The objectives of this study will be: (1) to pilot the methodological procedure of the randomized controlled trial using a standard auricular acupressure protocol for controlling CINV; (2) to determine the recruitment rate and attrition rate during the whole study period; (3) to determine the feasibility of the study questionnaires and auricular acupressure protocol to the study participants; (4) to identify potential adverse events associated with auricular acupressure; (5) to preliminarily examine the effects of auricular acupressure on CINV and QoL in female breast cancer patients receiving chemotherapy; (6) to explore patients' experience in completing the trial and receiving the intervention; and (7) to refine the study protocol for a future multicenter, large-scale randomized controlled trial.
A three-parallel-arm, placebo-controlled randomized pilot study will be adopted. One hundred and fourteen breast cancer patients scheduled to receive the first cycle of chemotherapy will be recruited from three provincial hospitals in Fuzhou, China, and will be randomly assigned to one of the three groups: the true AT group, the sham AT group or the standard care group. Participants in the true AT group will receive standard anti-emetic medications plus a 5-day auricular acupressure at the specific ear acupoints, participants in the sham AT group will receive standard anti-emetic medications plus a 5-day auricular acupressure at the same acupoints as in the true AT group without any acupoint stimulation, while participants in the standard care group will only be provided with the standard anti-emetic medications. The feasibility outcomes will be the recruitment rate and consent rate during the recruitment stage, the attrition rate during the whole study period, feasibility of the study questionnaires and auricular acupressure protocol to the study participants, and AT-related adverse events. The future main study outcomes will also be measured including acuteCINV, delayed CINV, anticipatory CINV, and quality of life. After completing the pilot clinical trial, a nested qualitative interview will be conducted to explore participants' experience in completing the trial and receiving the intervention.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Fujian
-
Fuzhou, Fujian, China, 350014
- Fujian Provincial Cancer Hospital
-
Fuzhou, Fujian, China, 350003
- The Second People's Hospital of Fujian Province
-
Fuzhou, Fujian, China, 350004
- The First People's Hospital of Fujian Province
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Adult female patients aged above 18 years old;
- A diagnosis of breast cancer stage I-III;
- Chemotherapy- naive;
- Auricular therapy-naive;
- Be able to communicate in Chinese mandarin;
- Have at least completed a primary school education;
- Agree to participate in the study and be willing to give written informed consent;
- Be scheduled to receive the first cycle of chemotherapy with moderately-high to highly emetogenic potentials;
- Be provided with standard antiemetic medications during chemotherapy.
Exclusion Criteria:
- Extremely weak, disabled or immunocompromised cancer patients;
- Be unable to follow the study instructions to do AT intervention or other research procedures;
- Have concurrent radiotherapy or other kinds of antineoplastic therapy;
- Currently take part in clinical studies on anti-emetic medications or other kinds of non-pharmacological interventions to control CINV, or other studies which are believed to produce potential interactions with this AT trial;
- Have other health problems which may affect the symptoms of CINV such as gastrointestinal disease, liver disease, migraine, tinnitus and Ménière's disease, etc.;
- Ear skin problems which are not appropriate for auricular acupressure including ear infections, ear scars and rashes, ear frostbite, and ear abscess, etc.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: True Auricular Acupressure Group
Participants in this group will receive standard antiemetics before and during chemotherapy, and a 5-day auricular acupressure treatment protocol for controlling nausea and vomiting during the first cycle of chemotherapy.
|
A 5-day auricular acupressure at the specific ear acupoints using vaccaria seeds.
Outros nomes:
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
Outros nomes:
|
Comparador Falso: Sham Auricular Acupressure Group
Participants in this group will receive standard antiemetic medications before and during chemotherapy, and a 5-day sham auricular acupressure intervention protocol during the first cycle of chemotherapy.
|
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
Outros nomes:
A 5-day sham auricular acupressure at the same acupoints as in the true auricular acupressure arm using Junci Medulla but no pressure will be applied.
Outros nomes:
|
Outro: Standard Care Group
Participants in this group will only receive standard anti-emetic treatment before and during chemotherapy.
|
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Recruitment Rate
Prazo: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Consent Rate
Prazo: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Attrition Rate
Prazo: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Feasibility of the Study Questionnaires and Auricular Acupressure Protocol
Prazo: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Potential Adverse Events associated with Auricular Acupressure
Prazo: During the 5-day intervention period
|
Feasibility outcome
|
During the 5-day intervention period
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Occurrence of Acute Vomiting
Prazo: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Frequency of Acute Vomiting
Prazo: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Occurrence of Acute Nausea
Prazo: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Severity of Acute Nausea
Prazo: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Occurrence of Delayed Vomiting
Prazo: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Frequency of Delayed Vomiting
Prazo: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Occurrence of Delayed Nausea
Prazo: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Severity of Delayed Nausea
Prazo: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Anticipatory Nausea and Vomiting
Prazo: The 1st day of the second chemotherapy cycle
|
The measure is a composite
|
The 1st day of the second chemotherapy cycle
|
Quality of Life Status
Prazo: The 21st day of the first chemotherapy cycle
|
Secondary outcome
|
The 21st day of the first chemotherapy cycle
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lorna SUEN, PhD, The Hong Kong Polytechnic University
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças de pele
- Neoplasias
- Neoplasias por local
- Sinais e Sintomas Digestivos
- Doenças da mama
- Neoplasias da Mama
- Náusea
- Vômito
- Efeitos Fisiológicos das Drogas
- Mecanismos Moleculares de Ação Farmacológica
- Agentes Autônomos
- Agentes do Sistema Nervoso Periférico
- Inibidores Enzimáticos
- Antiinflamatórios
- Agentes Antineoplásicos
- Agentes gastrointestinais
- Glicocorticóides
- Hormônios
- Hormônios, Substitutos Hormonais e Antagonistas Hormonais
- Agentes Antineoplásicos Hormonais
- Inibidores de Protease
- Dexametasona
- Acetato de dexametasona
- BB 1101
- Antieméticos
- Eméticos
Outros números de identificação do estudo
- HSEARS20150213001
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em True auricular acupressure
-
C. R. BardConcluídoEstenose da Válvula AórticaAlemanha
-
Shanghai General Hospital, Shanghai Jiao Tong University...Duke University; Rutgers University; Tsinghua UniversityConcluídoNão fumantes, adultos saudáveisChina
-
Procter and GambleConcluído
-
University Medicine GreifswaldNaemi-Wilke-Stift Guben Hospital - Anesthesia ServicesConcluído
-
Chengdu University of Traditional Chinese MedicineDesconhecidoDor pós-operatóriaChina
-
National Taiwan University HospitalConcluído
-
University of Medicine and Pharmacy at Ho Chi Minh...ConcluídoMudança de temperatura, corpoVietnã
-
Guangdong Provincial Hospital of Traditional Chinese...Concluído
-
Taipei Medical UniversityConcluídoDoenças das Glândulas SalivaresTaiwan
-
Johns Hopkins UniversityRescindidoNeuropatia Periférica Induzida por Quimioterapia (NPIC)Estados Unidos